Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

2.4K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

267
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
267
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

321
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
321
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

522
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
522
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

317
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
317
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

779
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
779

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving Statin Prescribing for People Living With HIV: A Quality Improvement Initiative.

JACC. Case reports·2026
Same author

Complete delivery matters: Multilevel complier average causal effect analysis of universal mental health curricula in two randomized controlled trials in U.K. schools.

Journal of consulting and clinical psychology·2026
Same author

Whole-protein screening and multi-modal profiling of antigen-specific CD4<sup>+</sup> T cells at single-cell resolution.

Nature communications·2026
Same author

Empowerment in Obesity and Behavioral Weight-Management Programmes: A Scoping Review.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2026
Same author

Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer.

Nature communications·2026
Same author

Vaginal mucosal melanoma recurrence with intracardiac metastasis treated with immunotherapy.

Gynecologic oncology reports·2026

Related Experiment Video

Updated: Jan 30, 2026

Comprehensive Assessment of Germline Chemical Toxicity Using the Nematode Caenorhabditis elegans
10:55

Comprehensive Assessment of Germline Chemical Toxicity Using the Nematode Caenorhabditis elegans

Published on: February 22, 2015

8.5K

Comprehensive Paired Tumor/Germline Testing for Lynch Syndrome: Bringing Resolution to the Diagnostic Process.

Monalyn U Salvador1, Melissa R F Truelson1, Carla Mason1

  • 11 Ambry Genetics, Aliso Viejo, CA.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|February 1, 2019
PubMed
Summary

Paired tumor and germline testing for Lynch syndrome (LS) improved diagnostic resolution in colorectal and endometrial cancers. This comprehensive approach offers a more complete evaluation for LS, identifying causes for mismatch-repair-deficient tumors.

More Related Videos

Establishment and Analysis of Tumor Slice Explants As a Prerequisite for Diagnostic Testing
11:00

Establishment and Analysis of Tumor Slice Explants As a Prerequisite for Diagnostic Testing

Published on: November 29, 2018

14.9K
Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
10:59

Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments

Published on: February 7, 2025

1.8K

Related Experiment Videos

Last Updated: Jan 30, 2026

Comprehensive Assessment of Germline Chemical Toxicity Using the Nematode Caenorhabditis elegans
10:55

Comprehensive Assessment of Germline Chemical Toxicity Using the Nematode Caenorhabditis elegans

Published on: February 22, 2015

8.5K
Establishment and Analysis of Tumor Slice Explants As a Prerequisite for Diagnostic Testing
11:00

Establishment and Analysis of Tumor Slice Explants As a Prerequisite for Diagnostic Testing

Published on: November 29, 2018

14.9K
Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
10:59

Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments

Published on: February 7, 2025

1.8K

Area of Science:

  • Oncology
  • Genetics
  • Cancer Diagnostics

Background:

  • Lynch syndrome (LS) diagnosis involves a complex, multi-step testing process.
  • Current algorithms often require sequential germline and somatic tests, increasing complexity.
  • A need exists for a more streamlined and efficient diagnostic approach.

Purpose of the Study:

  • To evaluate the utility of paired tumor and germline testing for Lynch syndrome.
  • To analyze results from a large cohort of colorectal cancer (CRC) and endometrial cancer (EC) patients.
  • To determine the diagnostic yield of this integrated testing methodology.

Main Methods:

  • Retrospective review of 702 CRC and EC patients undergoing paired tumor/germline LS gene analysis.
  • Inclusion of microsatellite instability, MLH1 promoter hypermethylation, and germline testing.
  • Patient grouping based on prior tumor screening and germline testing outcomes.

Main Results:

  • Paired testing provided informative LS diagnoses for 76.1% of CRC and 60.8% of EC patients.
  • LS germline mutations were found in 24.8% of patients without prior germline testing.
  • Biallelic somatic inactivation was observed in approximately 50% of mismatch-repair-deficient tumors.

Conclusions:

  • Paired testing effectively identified the cause of mismatch-repair-deficient tumors in a high percentage of patients.
  • Findings support integrating tumor sequencing and comprehensive germline testing into the LS diagnostic algorithm.
  • This paired approach offers a complete, convenient, and highly accurate evaluation for Lynch syndrome.